Evidence map›Paper›PMID 36251561›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Welder's Anthrax: A Tale of 2 Cases.

Katherine Hendricks, Roosecelis Brasil Martines, Hannah Bielamowicz, Anne E Boyer, Stephen Long, Paul Byers, Robyn A Stoddard, Kathryn Taylor, Cari Beesley Kolton, Maribel Gallegos-Candela and 12 more

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Pooled it
  2. Article
  3. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023
    Article
  4. Responding to the Threat Posed by Anthrax: Updated Evidence to Improve Preparedness.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  5. Article
  6. What Is Anthrax?Pathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

Katherine HendricksDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Roosecelis Brasil MartinesDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Hannah BielamowiczPathology Department, Fort Bend County Medical Examiner Office, Rosenberg, Texas, USA.
Anne E BoyerDivision of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Stephen LongHouston Laboratory Response Network, Houston Health Department, Houston, Texas, USA.
Paul ByersOffice of Communicable Diseases, Mississippi State Department of Health, Jackson, Mississippi, USA.
Robyn A StoddardDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kathryn TaylorOffice of Communicable Diseases, Mississippi State Department of Health, Jackson, Mississippi, USA.
Cari Beesley KoltonDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Maribel Gallegos-CandelaDivision of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Christine RobertsOffice of Communicable Diseases, Mississippi State Department of Health, Jackson, Mississippi, USA.
Marlene DeLeon-CarnesDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Johanna SalzerDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Patrick DawsonOffice of Science, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dannette BrownKing Daughters Medical Center, Brookhaven, Mississippi, USA.
Lindsey Templeton-LeBoufHouston Laboratory Response Network, Houston Health Department, Houston, Texas, USA.
Ryan C MavesDepartments of Infectious Diseases and Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Chris GulvikDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
David LonswayDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
John R BarrDivision of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
William A BowerDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-6538-8665
Alex HoffmasterDivision of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USMississippi State Department of Health · USHouston Health and Human Services Department · USKing's Daughters Medical Center · USWake Forest University · US

Funding

CDC HHS
6 · The paper itself

Abstract

Bacillus anthracis has traditionally been considered the etiologic agent of anthrax. However, anthrax-like illness has been documented in welders and other metal workers infected with Bacillus cereus group spp. harboring pXO1 virulence genes that produce anthrax toxins. We present 2 recent cases of severe pneumonia in welders with B. cereus group infections and discuss potential risk factors for infection and treatment options, including antitoxin.

Indexed as

AnthraxAntitoxinsBacillus anthracisBacillus cereusHumansMetal WorkersPlasmidsAntitoxinsantitoxinBacillus cereusBacillus tropicuswelder's anthraxwelding

Identifiers

PMID36251561
PMCPMC9649440
OpenAlexW4306632888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.